Commerce OVID

Ovid Therapeutics Inc

-

00:00:00

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Lire la suite...

OVID
Spécifications commerciales

Chiffres

3

Point

0.001

Diffusion

floating

Taille du contrat

1

Volume Min

1

Volume Max

10,000

Volume Étape

1

Échange long (points)

-0.460

Échange à découvert (Points)

-0.270
Disponible sur
MT5, TV, cTrader
Dernière mise à jour à juin 17, 20:08 GMT+3
*Source des données : MT5 Server Prime Account Pricing

OVID
Calendrier économique

Aucune donnée n'a été trouvée

1D Changement

206.604%

Pourquoi BlackBull ? marchés ?

26k+

Actifs négociables

1:500

Effet de levier jusqu’à

Réglementé

Multi-régulé

24/7

Soutien à la clientèle

$0

Pas de dépôt minimum

Calculateur de marge

Calculation Results

Current Price

0.76

Required Margin

Converted Currency

Required Margin

Account Base Currency

Calculateur de pertes et profits

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Calculateur de swaps

Calculation Results

0.76

Opportunités commerciales

Aucune donnée n'a été trouvée
Join Now